Introduction | 1, 3-di-o-(tert-butyl dimethylsilyl) calcipotriol is an important intermediate for synthesizing calcipotriol, which is a first-line drug for local treatment of psoriasis. Calcipotriol was marketed in Europe in 1991 and has been marketed in more than 80 countries and regions including the United States, China, Europe and Japan. |
Application | 1, 3-di-o-(tert-butyl dimethylsilyl) calcipotriol is an important intermediate in the synthesis of calcipotriol, a synthetic vitamin D derivative used in adult patients with psoriasis vulgaris (psoriasis), it is the first-line drug for local treatment of psoriasis. |
biological activity | impendence F of calcium triol is an Impurity of Calcipotriol, 25-dihydroxy vitamin D3 analog. |